Cognitive Behavioral Therapy for Fear of Recurrence
Fear of Recurrence and Stopping Immunotherapy
- Age
- 21 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 100 (estimated)
- Sponsor
- University of Pittsburgh · Other
This trial is looking for adults who are worried about stopping immunotherapy after cancer treatment. Participants will receive cognitive-behavioral therapy to help reduce their fear, anxiety, and improve their quality of life.
You may be able to join if
- I am 21 years or older
- I speak English fluently
- I have been diagnosed with cancer
- I have a history of treatment with immunotherapy
You may not be able to join if
- I have active suicidal thoughts
- I experience delusions or hallucinations
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Loading trial locations…